PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
60 hedge funds and large institutions have $168M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
Holders
60
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$5.28M | |
| 2 | +$4.41M | |
| 3 | +$1.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.25M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$948K |
Top Sellers
| 1 | -$3.53M | |
| 2 | -$454K | |
| 3 | -$310K | |
| 4 |
JP Morgan Chase
New York
|
-$112K |
| 5 |
E
Ergoteles
New York
|
-$111K |